Modulation of Nitrosative/Oxidative stress in the lung of hyperglycemic rabbits by two antidiabetics, pioglitazone and repaglinide

Experimental Lung Research

Volumn 35, Issue 5, 2009, Pages 371-379

  Gumieniczek, Anna ^a   Krzywdziska, Marta ^a   Nowak, Magdalena ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Hyperglycemia; Lung; Nitrosative oxidative stress; Pioglitazone; Repaglinide

Indexed keywords

3 NITROTYROSINE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; NITRITE; PIOGLITAZONE; REPAGLINIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HYPERGLYCEMIA; LIPID PEROXIDATION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CARBAMATES; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; LUNG; MALE; OXIDATIVE STRESS; PIPERIDINES; RABBITS; REACTIVE NITROGEN SPECIES; SUPEROXIDE DISMUTASE; THIAZOLIDINEDIONES; TYROSINE;

EID: 70849126615     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140902718536     Document Type: Article

References (37)

1. Ricardiollo F, Di Stefano A, Sabatini F, Folkerts G: Reactive nitrogen species in the respiratory tract. Eur J Pharmacol. 2006;533:240-252.
2. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C: Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia. 2001;44:834-838.
3. Nicolaie T, Zavoianu C, Nuta P: Pulmonary involvement in diabetes mellitus. Rom J Intern Med. 2003;41:365-374.
4. Chaudry J, Ghosh N,. Roy K, Chandra R: Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats. Life Sci. 2007;80:1135-1142.
5. MacNee W: Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol. 2001;429:195-207.
6. Inoue I, Goto S, Matsunaga T, Nakajima T, Awata T, Hokari S, Komoda T, Katayama S: The ligands/ activators for peroxisome proliferator-activated receptor ? (PPAR?) and PPAR? increase Cu+2,Zn+2-superoxide dismutase and decrease p22phox message expression in primary endothelial cells. Metabolism. 2001;50:3-11.
7. Rahbar S, Figarola JL: Novel inhibitors of advanced glycation endproducts. Arch Biochem Biophys. 2003;419:63-79.
8. Mizushige K, Tsuji T, Noma T: Pioglitazone: cardiovascular effects in prediabetic patients. Cardiovasc Drug Rev. 2002,20:329-334.
9. Pathan AR, Viswanad B, Sonkusare SK, Ramarao P: Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci. 2006;79:2209-2216.
10. Okada M, Yan SF, Pinski DJ: Peroxisome proliferator-activated receptor-gamma (PPARgamma) activation supresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEB J. 2002;16:1861-1868.
11. Wolffenbuttel BHR: Repaglinide-a new compound for the treatment of patients with with type 2 diabetes. Neth J Med. 1999;55:229-234.
12. Tankova T, Koev D, Dakovska L, Kirilov G: The effect of repaglinide on insulin secretion and oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pract. 2003;59:43-49.
13. Manzella D, Abbatecola AM, Grella R, Paolisso G: Repaglinide administration improves brachial reactivity in type 2 diabetic patients. Diabetes Care 2005;28:366-371.
14. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with Folin phenol reagent. J Biol Chem. 1951;193:265-267.
15. Granger DL, Taintor RR, Boockvar KS, Hibbs JB: Determination of nitrate and nitrite in biological sample using bacterial nitrate reductase coupled with the Griess reaction. Methods Enzymol. 1996;268:142-151.
16. Aebi H: Catalase in vitro. Methods Enzymol. 1984;105:121-126.
17. Paglia DE, Valentine WN: Studies on the qualitative and quantitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158-169.
18. Mize CE, Langdau RG: Hepatic glutathione reductase: I. Purification and general kinetic properties. J Biol Chem. 1962;237:1589-1595.
19. Liu K, Wu W, He W, Liu C: Ginkgo biloba extract (EGb 761) attenuates lung injury induced by intestinal ischemia/reperfusion in rats: roles of oxidative stress and nitric oxide.World J Gastroenterol. 2007;13:299-305.
20. Majithiya JB, Paramar AN, Balaraman PR: Pioglitazone, a PPAR? agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats. Cardiovasc Res. 2005;66:150-161.
21. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A: Oxidative stress and nitric oxide parameters in type II diabetes mellitus: effect of glycemic control. Clin Biochem. 2001;34:265-270.
22. Hurdag C, Uyaner I, Gurel E, Utkusavas A, Atukeren P, Demirci C: The effect of ?-lipoic acid on NOS dispersion in the lung of streptozotocin-induced diabetic rats. J Diabetes Complicat. 2008;22:56-61.
23. Hoeldtke RD: Nitrosative stress in early type 1 diabetes. Clin Auton Res. 2003;13:406-421.
24. Assaloni R, Da Ros R, Quagliaro L, Piconi L, Maier A, Zuodar G, Motz E, Ceriello A: Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients. Diabetologia 2005;48:1919-1924. (Pubitemid 41317849)
25. Ishii N, Patel KP, Lane PH, Taylor T, Bian K, Murad F, Pollock JS, Carmines PK: Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol. 2001;12:1630-1639.
26. Taniguchi J, Honda H, Shibusawa Y, Iwata T, Notoya Y. Alteration in endothelial function and modulation by treatment with pioglitazone in rabbit renal artery from short-term hypercholesterolemia. Vascul Pharmacol. 2005;43:47-55.
27. Gumieniczek A, Hopkala H, Rzymowska J, Niemczyk M: DNA oxidation and superoxide dismutase in the kidney of diabetic animals: effects of pioglitazone and repaglinide. Cent Eur J Biol. 2006;1:333-344.
28. Collino M, Aragno M, Mastrocola R, Gallicchio M, Rosa A, Dianzani C, Danni O, Thiemermann C, Fantozzi R: Modulation of the oxidative stress and inflammatory response by PPAR-? agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol. 2006;538:70-80. (Pubitemid 43037126)
29. Tao L, Liu H, Gao E, Teng Z, Lopez BL, Christopher TA, Ma X, Batinic-Haberle I, Willette RN, Ohlstein EH, Yue T: Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferators-activated receptor-? agonist in hypercholesterolemia. Circulation. 2003;108:2805-2811.
30. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriell A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Role of oxidative stress. Circulation. 2002;106:2067-2072.
31. Lang JD, McArdle PJ, O'Reilly PJ, Matalon S: Oxidant-antioxidant balance in acute lung injury. Chest 2002;122:314-320.
32. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Maffia P, Patel N, Di Paola R, Ialenti A, Genovese T, Chatterjee P, Di Rosa M, Caputi A, Thiemermann C: Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-?, reduces acute inflammation. Eur J Pharmacol. 2004;483:79-93. (Pubitemid 38056607)
33. Gumieniczek A: Modification of oxidative stress by pioglitazone in the heart of alloxan-induced diabetic rabbits. J Biol Sci. 2005;12:531-537. (Pubitemid 41032316)
34. Shiojiri T, Wada K, Nakajima A, Katayama K, Shibuya A, Kudo C, Kadowaki T, Mayumi T, Yura Y, Kamisaki Y: PPAR? ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice. Eur J Pharmacol. 2002;448:231-238.
35. Gumieniczek A: Effects of repaglinide on oxidative stress in tissues of diabetic rabbits. Diabetes Res Clin Pract. 2005;68:89-95.
36. Gumieniczek A: Oxidative stress in kidney and liver of alloxan-induced diabetic rabbits: effect of repaglinide. Acta Diabetol. 2005;42:75-81. (Pubitemid 40881111)
37. Choi S, Benzie IFF, Ma S, Strain JJ, Hannigan BM: Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radic Biol Med. 2008;44:1217-1231.